Moreover, since genetic mutations in core components of the TGF-β signalling pathway, such as SMAD4,21 are very frequent in some tumours, we decided to rule out this mechanism of escape from TGF-β suppressor effects in iCCA. This evidence concerns the gene SMAD4 and neoplasm.